Upgrade to SI Premium - Free Trial

Milestone Pharmaceuticals Inc. (MIST)

1.22 +0.01 (0.83%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form EFFECT Milestone Pharmaceutical May 26, 2026 6:04 AM - SEC Filing Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: RTW INVESTMENTS, LP May 15, 2026 8:26 AM - SEC Filing Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ May 14, 2026 8:30 AM - Globe NewsWire Milestone Pharmaceuticals (MIST) PT Lowered to $7 at Wells Fargo May 14, 2026 6:56 AM - StreetInsider Form S-3 Milestone Pharmaceutical May 13, 2026 5:29 PM - SEC Filing Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: Adage Capital Management, L.P. May 13, 2026 9:10 AM - SEC Filing Form 8-K Milestone Pharmaceutical For: May 13 May 13, 2026 7:23 AM - SEC Filing Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 43c May 13, 2026 7:17 AM - StreetInsider Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update May 13, 2026 7:11 AM - Globe NewsWire Form 10-Q Milestone Pharmaceutical For: Mar 31 May 13, 2026 7:05 AM - SEC Filing Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 May 6, 2026 8:00 AM - Globe NewsWire Form ARS Milestone Pharmaceutical For: Dec 31 April 30, 2026 4:16 PM - SEC Filing Form DEFA14A Milestone Pharmaceutical April 30, 2026 4:13 PM - SEC Filing Form DEF 14A Milestone Pharmaceutical For: Jun 10 April 30, 2026 4:09 PM - SEC Filing Form 4 Milestone Pharmaceutical For: Apr 16 Filed by: Oliveto Joseph April 20, 2026 4:06 PM - SEC Filing Form 144 Milestone Pharmaceutical Filed by: Oliveto Joseph April 16, 2026 4:12 PM - SEC Filing Milestone launches registry to study CARDAMYST nasal spray use April 10, 2026 8:01 AM - StreetInsider Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT April 10, 2026 8:00 AM - Globe NewsWire Raymond James Starts Milestone Pharmaceuticals (MIST) at Strong Buy, ' Buy Before the Fear of MISTing Out' April 9, 2026 4:25 PM - StreetInsider Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference April 7, 2026 12:48 PM - Globe NewsWire Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 2, 2026 8:00 AM - Globe NewsWire Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies March 31, 2026 8:01 AM - Globe NewsWire Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: Trails Edge Capital Partners, LP March 26, 2026 5:37 PM - SEC Filing Form 3 Milestone Pharmaceutical For: Mar 17 Filed by: Sandoval David I. March 23, 2026 6:51 PM - SEC Filing Form 8-K Milestone Pharmaceutical For: Mar 20 March 20, 2026 7:25 AM - SEC Filing Form 10-K Milestone Pharmaceutical For: Dec 31 March 20, 2026 7:08 AM - SEC Filing Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session March 16, 2026 8:13 AM - Globe NewsWire Milestone Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 20, 2026 March 12, 2026 8:01 AM - Globe NewsWire Full Article List